Soaring costs in the $2.6 trillion U.S. healthcare economy are posing ever-greater challenges to health technology innovators.

01.

New technologies must improve healthcare outcomes while simultaneously saving healthcare dollars;

02.

New technologies must be developed economically and brought to market ready to generate returns expeditiously with minimized regulatory and reimbursement risks;

03.

Disappointing returns by very large health-tech venture funds (>$500M) has caused a decline in traditional source innovation-funding leaving a disproportionate number of health-tech opportunities seeking funding;

04.

We have extensive hands-on operating and intellectual property experience to help (and, in some cases, actively manage) enterprises and new technologies and bring them to market quickly and efficiently.